VEGFA and hypertensive disorder: On the other hand, as for specific cardiovascular AEs, hypertension, to date, is the most frequently reported and best characterized cardiovascular toxicity associated with angiogenesis inhibitors targeting VEGF (9, 16, 17, 26, 27).